Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
…, R Lafyatis, G Stifano, H Spotswood, H Chen-Harris… - The lancet, 2016 - thelancet.com
Background Systemic sclerosis is a rare disabling autoimmune disease with few treatment
options. The efficacy and safety of tocilizumab, an interleukin 6 receptor-α inhibitor, was …
options. The efficacy and safety of tocilizumab, an interleukin 6 receptor-α inhibitor, was …
Adaptive control of saccades via internal feedback
H Chen-Harris, WM Joiner, V Ethier… - Journal of …, 2008 - Soc Neuroscience
Ballistic movements like saccades require the brain to generate motor commands without
the benefit of sensory feedback. Despite this, saccades are remarkably accurate. Theory …
the benefit of sensory feedback. Despite this, saccades are remarkably accurate. Theory …
Cerebellar contributions to adaptive control of saccades in humans
M Xu-Wilson, H Chen-Harris, DS Zee… - Journal of …, 2009 - Soc Neuroscience
The cerebellum may monitor motor commands and through internal feedback correct for
anticipated errors. Saccades provide a test of this idea because these movements are …
anticipated errors. Saccades provide a test of this idea because these movements are …
[HTML][HTML] Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
…, J Greally, S Jhunjhunwala, H Chen-Harris - Nature …, 2019 - nature.com
Profound global loss of DNA methylation is a hallmark of many cancers. One potential
consequence of this is the reactivation of transposable elements (TEs) which could stimulate the …
consequence of this is the reactivation of transposable elements (TEs) which could stimulate the …
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in …
CP Denton, VH Ong, S Xu, H Chen-Harris… - Annals of the …, 2018 - ard.bmj.com
Objectives Skin fibrosis mediated by activated dermal fibroblasts is a hallmark of systemic
sclerosis (SSc), especially in the subset of patients with diffuse disease. Transforming growth …
sclerosis (SSc), especially in the subset of patients with diffuse disease. Transforming growth …
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration
YW Lim, H Chen-Harris, O Mayba… - Proceedings of the …, 2018 - National Acad Sciences
Cancer immunotherapy has emerged as an effective therapy in a variety of cancers. However,
a key challenge in the field is that only a subset of patients who receive immunotherapy …
a key challenge in the field is that only a subset of patients who receive immunotherapy …
[PDF][PDF] RIPK3 activation leads to cytokine synthesis that continues after loss of cell membrane integrity
…, N Yatim, MN Messmer, G Quarato, H Chen-Harris… - Cell reports, 2019 - cell.com
Necroptosis is a form of programmed cell death that is defined by activation of the kinase
RIPK3 and subsequent cell membrane permeabilization by the effector MLKL. RIPK3 activation …
RIPK3 and subsequent cell membrane permeabilization by the effector MLKL. RIPK3 activation …
[HTML][HTML] Two escape mechanisms of influenza A virus to a broadly neutralizing stalk-binding antibody
N Chai, LR Swem, M Reichelt, H Chen-Harris… - PLoS …, 2016 - journals.plos.org
Broadly neutralizing antibodies targeting the stalk region of influenza A virus (IAV)
hemagglutinin (HA) are effective in blocking virus infection both in vitro and in vivo. The highly …
hemagglutinin (HA) are effective in blocking virus infection both in vitro and in vivo. The highly …
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
…, E Guardino, H Chen-Harris… - Proceedings of the …, 2020 - National Acad Sciences
PD-1 and PD-L1 act to restrict T cell responses in cancer and contribute to self-tolerance.
Consistent with this role, PD-1 checkpoint inhibitors have been associated with immune-…
Consistent with this role, PD-1 checkpoint inhibitors have been associated with immune-…
Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model
…, O Siddiqui, D Sheinson, H Chen-Harris… - Antimicrobial agents …, 2017 - Am Soc Microbiol
MHAA4549A, a human monoclonal antibody targeting the hemagglutinin stalk region of
influenza A virus (IAV), is being developed as a therapeutic for patients hospitalized with severe …
influenza A virus (IAV), is being developed as a therapeutic for patients hospitalized with severe …